These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
800 related items for PubMed ID: 19426671
1. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway. Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH. Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671 [Abstract] [Full Text] [Related]
2. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
3. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression. Lee J, Hwangbo C, Lee JJ, Seo J, Lee JH. Oncol Rep; 2010 Jan 07; 23(1):229-37. PubMed ID: 19956887 [Abstract] [Full Text] [Related]
4. Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. Fandy TE, Srivastava RK. Cancer Chemother Pharmacol; 2006 Oct 07; 58(4):471-7. PubMed ID: 16435155 [Abstract] [Full Text] [Related]
5. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY. Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429 [Abstract] [Full Text] [Related]
6. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells. Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH. Exp Cell Res; 2009 Jul 01; 315(11):1809-18. PubMed ID: 19268463 [Abstract] [Full Text] [Related]
7. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK. Free Radic Biol Med; 2008 Mar 15; 44(6):1055-68. PubMed ID: 18164688 [Abstract] [Full Text] [Related]
8. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells. Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A. Gynecol Oncol; 2004 Jun 15; 93(3):594-604. PubMed ID: 15196850 [Abstract] [Full Text] [Related]
9. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasome-mediated c-FLIPS down-regulation. Kim JY, Kim EH, Park SS, Lim JH, Kwon TK, Choi KS. J Cell Biochem; 2008 Dec 15; 105(6):1386-98. PubMed ID: 18980244 [Abstract] [Full Text] [Related]
11. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX, Ong CN, Shen HM. Cancer Res; 2005 Sep 01; 65(17):7815-23. PubMed ID: 16140950 [Abstract] [Full Text] [Related]
12. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. Tomek S, Horak P, Pribill I, Haller G, Rössler M, Zielinski CC, Pils D, Krainer M. Gynecol Oncol; 2004 Jul 01; 94(1):107-14. PubMed ID: 15262127 [Abstract] [Full Text] [Related]
13. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S, Liu X, Yue P, Schönthal AH, Khuri FR, Sun SY. Mol Pharmacol; 2007 Nov 01; 72(5):1269-79. PubMed ID: 17684158 [Abstract] [Full Text] [Related]
14. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells. Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C. Cell Signal; 2007 Nov 01; 19(11):2237-46. PubMed ID: 17693058 [Abstract] [Full Text] [Related]
15. Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3. Choi WY, Jin CY, Han MH, Kim GY, Kim ND, Lee WH, Kim SK, Choi YH. Anticancer Res; 2009 Nov 01; 29(11):4457-65. PubMed ID: 20032392 [Abstract] [Full Text] [Related]
16. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY, Kim MJ, Chung HY, Lee SJ, Jang YJ. Oncol Rep; 2007 Jan 01; 17(1):175-84. PubMed ID: 17143496 [Abstract] [Full Text] [Related]
17. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S. Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424 [Abstract] [Full Text] [Related]
18. The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation. Carlisi D, Lauricella M, D'Anneo A, Emanuele S, Angileri L, Di Fazio P, Santulli A, Vento R, Tesoriere G. Eur J Cancer; 2009 Sep 01; 45(13):2425-38. PubMed ID: 19643600 [Abstract] [Full Text] [Related]
19. Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Lee TJ, Um HJ, Min do S, Park JW, Choi KS, Kwon TK. Free Radic Biol Med; 2009 Jun 15; 46(12):1639-49. PubMed ID: 19345731 [Abstract] [Full Text] [Related]
20. Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, Yun CO, Choi KS. Cancer Res; 2007 Sep 01; 67(17):8274-84. PubMed ID: 17804742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]